Wall Street was in positive territory on Thursday but surrendered strong earlier gains after a report that an experimental antiviral drug for the coronavirus flopped in its first randomized clinical trial. All three main US stock indexes trimmed increases of over 1 percent, with the S&P 500 and Nasdaq briefly turning negative after the Financial Times reported that a Chinese …
)